Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0158282 TUNGSTATE TREATMENT OF THE DYSBIOSIS ASSOCIATED WITH GASTROINTESTINAL INFLAMMATION
The present invention provides compositions of therapeutic agents and methods of use for reducing and/or treating gastrointestinal inflammation. In particular...
2016/0158281 Surface-Modified Heavy Metal Nanoparticles, Compositions And Uses Thereof
Surface-modified heavy metal nanoparticles, including a heavy metal core and a coating layer, the coating layer having at least one ligand, conjugated to...
2016/0158280 A METHOD FOR ORGAN ARREST, PROTECTION AND PRESERVATION AND REDUCING TISSUE INJURY
The invention relates to compositions and methods for Inducing organ arrest, maintaining arrest and reanimating in a subject that has suffered a life...
2016/0158279 SYSTEMS AND METHODS FOR DELIVERY OF PEPTIDES
The present invention generally relates to compositions and methods for topical or transdermal delivery. The compositions can be used in a variety of...
2016/0158278 BRAIN AND NEURAL TREATMENTS COMPRISING PEPTIDES AND OTHER COMPOSITIONS
The present invention generally relates to compositions and methods for treatment of subjects in need of muscle growth, muscle repair, improved muscular and...
2016/0158277 IMMUNE MODULATION USING PEPTIDES AND OTHER COMPOSITIONS
The present invention generally relates to compositions and methods for topical or transdermal delivery for immune modulation. In some cases, the composition...
2016/0158276 PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES USING SYSTEMS AND METHODS FOR TRANSDERMAL NITRIC OXIDE DELIVERY
The present invention generally relates to compositions and methods for treatment of subjects having or at risk of arteriosclerosis, hypertension, sickle-cell...
2016/0158275 PHARMACEUTICAL COMPOSITIONS
The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine...
2016/0158274 COMPOSITION FOR MUCOUS DISPERSION OR HYDRATION, CONTAINING POLY-r-GLUTAMIC ACID
The present invention relates to a composition for dispersing or hydrating mucus, which comprises poly-gamma-glutamic acid, a biocompatible natural polymer,...
2016/0158273 BATHWATER AND SOAK ADDITIVE
The present disclosure generally relates to a bathwater additive which renders the bathwater viscous and slippery.
2016/0158272 OPHTHALMIC COMPOSITIONS COMPRISING POLYETHER SUBSTITUTED POLYMERS
The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about...
2016/0158271 INHIBITORS OF ADAMTS4 OR ADAMTS5 FOR USE IN PREVENTING OR TREATING CARDIAC REMODELING AND CHRONIC HEART FAILURE
The present invention provides an inhibitor of an ADAMTS proteoglycanase for use in treating or preventing cardiac remodeling or for use in treating or...
2016/0158270 BIOMATERIALS COMPRISING HYALURONIC ACID BINDING PEPTIDES AND EXTRACELLULAR MATRIX BINDING PEPTIDES FOR...
The present invention provides novel biomaterial compositions and methods having a technology to improve retention of hyaluronic acid (HA). The biomaterial...
2016/0158269 Nutraceutical Composition And Methods For Prevention Or Treating Multiple Sclerosis
The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing...
2016/0158268 METHOD OF REDUCING INTRAOCULAR PRESSURE IN HUMANS
Provided herein is a method of reducing intraocular pressure (IOP) in humans using N6-cyclopentyladenosine (CPA), CPA derivatives or prodrugs or enhanced...
2016/0158267 METHODS OF PREVENTING, REDUCING OR TREATING MACULAR DEGENERATION
The present invention is directed to selective adenosine A.sub.1 agonist compounds, pharmaceutical compositions comprising such compounds, and methods of using...
2016/0158266 2' FLUORONUCLEOSIDES
2'-Fluoro-nucleoside compounds are disclosed which are useful in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cellular...
2016/0158265 ISOLATION OF NOVEL BIOACTIVE COMPOUND OBTAINED FROM OIL PALM BASE MATERIALS
Present invention relates to a composition comprising novel bioactive compound obtained from oil palm based materials and the method of isolating bioactive...
2016/0158264 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired...
2016/0158263 TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an...
2016/0158262 METHODS OF TREATING IRRITABLE BOWEL SYNDROME
The present invention provides a method for treating irritable bowel syndrome (IBS) in a subject in need thereof. The treatment can include administering about...
2016/0158261 Antibiotic Kit and Composition and Uses Thereof
The present invention relates to a therapeutic kit to provide a safe and effective dosage of an antibiotic agent, including an aerosol packaging assembly...
2016/0158260 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes
Disclosed are inhibitors of post-proline cleavage enzymes, such as inhibitors of dipeptidyl peptidase IV, as well as pharmaceutical compositions thereof, and...
2016/0158259 METHODS OF TREATING RETROVIRAL INFECTIONS AND RELATED DOSAGE REGIMES
The present invention relates to compounds and methods for treating retroviral infections and/or Hepatitis B viral infections. Some compounds of the invention...
2016/0158258 PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS
In accordance with some embodiments herein, methods and compositions for prevention and treatment of inflammatory conditions are provided. In some embodiments,...
2016/0158257 DIETARY SUPPLEMENT CONTAINING PHOSPHOLIPID-DHA DERIVED FROM EGGS
Described herein are manufactured dietary supplements that contain a phospholipid extract, folic acid, vitamin D, vitamin B.sub.6, vitamin B.sub.12, Vitamin E,...
2016/0158256 Dosage Forms for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The bioavailability of...
2016/0158255 Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Paget's Disease of Bone
Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabillty...
2016/0158254 Dosage Forms For Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions, such as complex regional...
2016/0158253 TREATMENT OF PANCREATIC CANCER WITH A COMBINATION OF A HYPOXIA-ACTIVATED PRODRUG AND A TAXANE
Combined administration of a hypoxia-activated prodrug, such as TH-302, a taxane, such as nab-paclitaxel, and a nucleoside analog chemotherapeutic, such as...
2016/0158252 PHARMACEUTICAL COMPOSITION AND USE OF DIETHYL (2-CYANOETHYL)PHOSPHONATE
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and diethyl (2-cyanoethyl)phosphonate, or a...
2016/0158251 COMPOSITION FOR PREVENTING OR TREATING MUSCULAR ATROPHY OR PROMOTING MUSCULAR REGENERATION IN SUBJECT...
A composition for preventing or treating muscular atrophy or promoting muscular regeneration in a subject including a sulfonamide compound, a pharmaceutically...
2016/0158250 METHODS AND PRODUCTS FOR TREATMENT OF DISEASES
The invention provides a method of treating a disease or condition mediated by vascular hyperpermeability in an animal. The method comprises administering an...
2016/0158249 OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRATING POSTERIOR SEGMENT TISSUES
Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component that includes...
2016/0158248 METHODS AND SYSTEMS FOR THE DELIVERY OF A THERAPEUTIC AGENT
The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example,...
2016/0158247 Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
This disclosure is directed to treatment of addictions and primary impulse-control disorders using phosphodiesterase 7 (PDE7) inhibitors, alone or in...
2016/0158246 METHOD OF TREATING DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) USING A BET-BROMODOMAIN INHIBITOR
A method of treating diffuse large B-cell lymphoma comprising administering to a patient a pharmaceutically acceptable amount of a composition comprising a...
2016/0158245 PHARMACEUTICAL FORMULATION CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS
A method of treating lymphoblastic leukemia, acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia or CD34 positive acute myeloid leukemia...
2016/0158244 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER AND OTHER DISEASES OR DISORDERS
This invention provides novel pharmaceutical compositions of the compound of formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof, that are...
2016/0158243 IGF-1R SIGNALING PATHWAY INHIBITORS USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
The present invention provides compounds acting as Insulin/IGF signaling modulators useful in the treatment of neurodegenerative diseases and disorders. The...
2016/0158242 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
The present invention relates to novel compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid...
2016/0158241 N,6-BIS(ARYL OR HETEROARYL)-1,3,5-TRIAZINE-2,4-DIAMINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT...
Provided are compounds of formula (I), Wherein: ring A and ring B are each independently an optionally substituted 5-6 membered monocyclic aryl or heteroaryl....
2016/0158240 Compositions Containing Defined Caffeine and Theobromine Levels with Enhanced Cognitive Properties
The invention includes compositions and methods for improving cognitive function or reducing the anxiety effects of caffeine cravings. Caffeine and theobromine...
2016/0158239 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities...
2016/0158238 Pteridines Useful As HCV Inhibitors And Methods For The Preparation Thereof
The present invention relates to the use of pteridines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or...
2016/0158237 Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
The present invention provides methods and compositions for treating thyroid-related medical conditions. Many thyroid-related medical conditions exist that go...
2016/0158236 PHARMACEUTICAL COMPOSITION COMPRISING A TRPA1 ANTAGONIST AND A STEROID
The present patent application relates to a pharmaceutical composition comprising a transient receptor potential ankyrin-1 receptor ("TRPA1") antagonist and a...
2016/0158235 BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITORS
The present invention provides diagnostic and prognostic methods for predicting the effectiveness of treatment of a cancer patient with an EGFR kinase...
2016/0158234 BIHETEROARYL COMPOUNDS AND USES THEREOF
The present invention provides for compounds of Formula I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases)....
2016/0158233 SGC STIMULATORS OR SGC ACTIVATORS AND PDE5 INHIBITORS IN COMBINATION WITH ADDITIONAL TREATMENT FOR THE THERAPY...
The present invention relates to soluble guanylate cyclase (sGC) and to phosphodiesterases (PDEs) and the pharmacology of sGC stimulators, sGC activators and...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.